SC 13G/A: 4D Molecular Therapeutics, Inc.
Ticker: FDMT · Form: SC 13G/A · Filed: Dec 6, 2024 · CIK: 1650648
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by 4D Molecular Therapeutics, Inc..
Risk Assessment
Risk Level: low
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on December 6, 2024 regarding 4D Molecular Therapeutics, Inc. (FDMT).